{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:46:19Z","timestamp":1784069179999,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:00:00Z","timestamp":1539043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703492"],"award-info":[{"award-number":["81703492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7182092"],"award-info":[{"award-number":["7182092"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s12031-018-1165-4","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:55:04Z","timestamp":1539046504000},"page":"428-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia"],"prefix":"10.1007","volume":"66","author":[{"given":"Zhi-Le","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Xu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-En","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7529-4408","authenticated-orcid":false,"given":"Yong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"issue":"5","key":"1165_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1089\/jmf.2013.0065","volume":"17","author":"OM Abdel-Salam","year":"2014","unstructured":"Abdel-Salam OM, Youness ER, Mohammed NA, Morsy SM, Omara EA, Sleem AA (2014) Citric acid effects on brain and liver oxidative stress in lipopolysaccharide-treated mice. J Med Food 17(5):588\u2013598","journal-title":"J Med Food"},{"key":"1165_CR2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0278-5846(02)00220-8","volume":"26","author":"O Akyol","year":"2002","unstructured":"Akyol O, Herken H, Uza E, Fad\u0131ll\u0131og E, Ozyurta H, Savas HA (2002) The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. Prog Neuro-Psychopharmacol Biol Psychiatry 26:995\u20131005","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"1165_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pnpbp.2007.08.003","volume":"32","author":"L Ben Othmen","year":"2008","unstructured":"Ben Othmen L, Mechri A, Fendri C et al (2008) Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings. Prog Neuro-Psychopharmacol Biol Psychiatry 32(1):155\u2013159","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"3","key":"1165_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.psychres.2013.08.035","volume":"210","author":"M Boskovic","year":"2013","unstructured":"Boskovic M, Grabnar I, Terzic T, Kores Plesnicar B, Vovk T (2013) Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate. Psychiatry Res 210(3):761\u2013768","journal-title":"Psychiatry Res"},{"issue":"2","key":"1165_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF02912908","volume":"21","author":"G Dadheech","year":"2006","unstructured":"Dadheech G, Mishra S, Gautam S, Sharma P (Sep 2006) Oxidative stress, alpha-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics. Indian J Clin Biochem 21(2):34\u201338","journal-title":"Indian J Clin Biochem"},{"issue":"10","key":"1165_CR6","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","volume":"12","author":"KQ Do","year":"2000","unstructured":"Do KQ, Trabesinger AH, Kirsten-Kruger M et al (2000) Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12(10):3721\u20133728","journal-title":"Eur J Neurosci"},{"key":"1165_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cbpa.2016.05.008","volume":"200","author":"R Dzul-Caamal","year":"2016","unstructured":"Dzul-Caamal R, Salazar-Coria L, Olivares-Rubio HF, Rocha-Gomez MA, Giron-Perez MI, Vega-Lopez A (Oct 2016) Oxidative stress response in the skin mucus layer of Goodea gracilis (Hubbs and Turner, 1939) exposed to crude oil: a non-invasive approach. Comp Biochem Physiol A Mol Integr Physiol 200:9\u201320","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"issue":"1","key":"1165_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S1461145710000805","volume":"14","author":"JW Gawryluk","year":"2011","unstructured":"Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14(1):123\u2013130","journal-title":"Int J Neuropsychopharmacol"},{"key":"1165_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.pnpbp.2006.09.012","volume":"31","author":"S Grignon","year":"2007","unstructured":"Grignon S, Chianetta JM (2007) Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations. Prog Neuro-Psychopharmacol Biol Psychiatry 31:365\u2013369","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1165_CR10","unstructured":"Guzelhan Y, Sayar K, Ozturk M, Kara I (2000) Free radicals in schizophrenia. Bull Clin Psycophamacol"},{"key":"1165_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.mp.4000789","volume":"6","author":"H Herken","year":"2001","unstructured":"Herken H, Uz E, Ozyurt H, Sogut S, Virit O, Akyol O (2001) Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry 6:66\u201373","journal-title":"Mol Psychiatry"},{"issue":"6","key":"1165_CR12","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.chemosphere.2011.06.078","volume":"85","author":"OI Kubrak","year":"2011","unstructured":"Kubrak OI, Husak VV, Rovenko BM, Storey JM, Storey KB, Lushchak VI (Oct 2011) Cobalt-induced oxidative stress in brain, liver and kidney of goldfish Carassius auratus. Chemosphere 85(6):983\u2013989","journal-title":"Chemosphere"},{"key":"1165_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/cbf.940","volume":"20","author":"M Kuloglu","year":"2002","unstructured":"Kuloglu M, Ustundag B, Atmaca M, Canatan H, Ertan Tezcan A, Cinkilinc N (2002a) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 20:171\u2013175","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"1165_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/cbf.940","volume":"20","author":"M Kuloglu","year":"2002","unstructured":"Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N (Jun 2002b) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 20(2):171\u2013175","journal-title":"Cell Biochem Funct"},{"key":"1165_CR15","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.pnpbp.2008.07.001","volume":"32","author":"M Kunz","year":"2008","unstructured":"Kunz M, Gama CS, Andreazza AC, Salvador M, Ceres\u00e9r KM, Gomes FA, Belmonte-de-Abreu PS, Berk M, Kapczinski F (2008) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuro-Psychopharmacol Biolog Psychiatry 32:1677\u20131681","journal-title":"Prog Neuro-Psychopharmacol Biolog Psychiatry"},{"issue":"1\u20132","key":"1165_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0952-3278(96)90144-1","volume":"55","author":"SP Mahadik","year":"1996","unstructured":"Mahadik SP, Scheffer RE (1996) Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fat Acids 55(1\u20132):45\u201354","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"2","key":"1165_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/09540260600581993","volume":"18","author":"SP Mahadik","year":"2006","unstructured":"Mahadik SP, Pillai A, Joshi S, Foster A (2006) Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia. Int Rev Psychiatry 18(2):119\u2013131","journal-title":"Int Rev Psychiatry"},{"issue":"1","key":"1165_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0006-3223(02)01443-9","volume":"53","author":"SS Meena Arvindakshan","year":"2003","unstructured":"Meena Arvindakshan SS, Debsikdar V, Ghate M, Evans D, Horrobin DF, Bennett C, Ranjekar PK, Mahadik SP (2003) Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry 53(1):56\u201364","journal-title":"Biol Psychiatry"},{"key":"1165_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.psychres.2017.01.043","volume":"249","author":"AL Morera-Fumero","year":"2017","unstructured":"Morera-Fumero AL, Diaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, Cejas-Mendez MD (2017) Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day\/night change as a marker of acute paranoid schizophrenia relapse. Psychiatry Res 249:200\u2013205","journal-title":"Psychiatry Res"},{"issue":"1","key":"1165_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0920-9964(95)00048-8","volume":"19","author":"S Mukherjee","year":"1996","unstructured":"Mukherjee S, Mahadik SP, Scheffer R, Correnti EE, Kelkar H (1996) Impaired antioxidant defense at the onset of psychosis. Schizophr Res 19(1):19\u201326","journal-title":"Schizophr Res"},{"issue":"1","key":"1165_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cca.2003.11.006","volume":"137","author":"EO Oruc","year":"2004","unstructured":"Oruc EO, Sevgiler Y, Uner N (2004) Tissue-specific oxidative stress responses in fish exposed to 2,4-D and azinphosmethyl. Comp Biochem Physiol Toxicol Pharmacol 137(1):43\u201351","journal-title":"Comp Biochem Physiol Toxicol Pharmacol"},{"key":"1165_CR22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/0717-6287-47-5","volume":"47","author":"GA Otunola","year":"2014","unstructured":"Otunola GA, Oloyede OB, Oladiji AT, Afolayan AJ (2014) Selected spices and their combination modulate hypercholesterolemia-induced oxidative stress in experimental rats. Biol Res 47:5","journal-title":"Biol Res"},{"issue":"1","key":"1165_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12640-012-9335-6","volume":"23","author":"L Pomierny-Chamiolo","year":"2013","unstructured":"Pomierny-Chamiolo L, Moniczewski A, Wydra K, Suder A, Filip M (Jan 2013) Oxidative stress biomarkers in some rat brain structures and peripheral organs underwent cocaine. Neurotox Res 23(1):92\u2013102","journal-title":"Neurotox Res"},{"issue":"2","key":"1165_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pnpbp.2012.07.013","volume":"39","author":"M Raffa","year":"2012","unstructured":"Raffa M, Barhoumi S, Atig F, Fendri C, Kerkeni A, Mechri A (2012) Reduced antioxidant defense systems in schizophrenia and bipolar I disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 39(2):371\u2013375","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"1165_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","volume":"121","author":"PK Ranjekar","year":"2003","unstructured":"Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP (2003) Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121(2):109\u2013122","journal-title":"Psychiatry Res"},{"issue":"4","key":"1165_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0006-3223(91)90298-Z","volume":"30","author":"R Reddy","year":"1991","unstructured":"Reddy R, Sahebarao MP, Mukherjee S, Murthy JN (1991) Enzymes of the antioxidant defense system in chronic schizophrenic patients. Biol Psychiatry 30(4):409\u2013412","journal-title":"Biol Psychiatry"},{"issue":"2","key":"1165_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/BF02894268","volume":"19","author":"MS Rukmini","year":"2004","unstructured":"Rukmini MS, D'Souza B, D'Souza V (Jul 2004) Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients. Indian J Clin Biochem 19(2):114\u2013118","journal-title":"Indian J Clin Biochem"},{"issue":"6","key":"1165_CR28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.pnpbp.2007.03.008","volume":"31","author":"A Sarandol","year":"2007","unstructured":"Sarandol A, Kirli S, Akkaya C, Altin A, Demirci M, Sarandol E (2007) Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 31(6):1164\u20131169","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"1165_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2004.10.010","volume":"76","author":"AO Skinner","year":"2005","unstructured":"Skinner AO, Mahadik SP, Garver DL (2005) Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia. Schizophr Res 76(1):83\u201387","journal-title":"Schizophr Res"},{"key":"1165_CR30","unstructured":"Sorokin AM, Moiseeva NB, Cheredeev AN, Frolova IS (1988) The interferon-natural killer cell system of patients with ovarian tumors. Akush Ginekol (Mosk) (5):23\u201327"},{"issue":"3\u20134","key":"1165_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000363515","volume":"72","author":"P Wang","year":"2014","unstructured":"Wang P, Xie K, Wang C, Bi J (2014) Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis. Eur Neurol 72(3\u20134):249\u2013254","journal-title":"Eur Neurol"},{"issue":"6","key":"1165_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0022-3956(98)00028-4","volume":"32","author":"JK Yao","year":"1998","unstructured":"Yao JK, Reddy R, McElhinny LG, van Kammen DP (1998) Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. J Psychiatr Res 32(6):385\u2013391","journal-title":"J Psychiatr Res"},{"issue":"2\u20133","key":"1165_CR33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","volume":"81","author":"XY Zhang","year":"2006","unstructured":"Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, Zhou DF (2006) Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res 81(2\u20133):291\u2013300","journal-title":"Schizophr Res"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-018-1165-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-018-1165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-018-1165-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T09:47:07Z","timestamp":1605174427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-018-1165-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1007\/s12031-018-1165-4","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,9]]},"assertion":[{"value":"21 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Before inclusion in this study, all participants gave written informed consent. The study protocol has been approved by the Ethics Committee at The Third Hospital of Fuoshan, Fuoshan, China, and the experiments were conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}